Zobrazeno 1 - 10
of 234
pro vyhledávání: '"R Rinehart"'
Autor:
Jessica M. Fogel, Estelle Piwowar-Manning, Amber Moser, Tinia Hill, Shahnaz Ahmed, Vanessa Cummings, Heba H. Mostafa, Zhe Wang, Andrea Jennings, Jorge A. Gallardo-Cartagena, María Inés Figueroa, Marty St Clair, Alex R. Rinehart, Adeola Adeyeye, James F. Rooney, Myron S. Cohen, Beatriz Grinsztejn, Raphael J. Landovitz, Susan H. Eshleman
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 8 (2024)
ABSTRACT Detection of HIV infection may be challenging in persons using long-acting cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) due to viral suppression and reduced/delayed antibody production. We evaluated two point-of-care tests for detec
Externí odkaz:
https://doaj.org/article/0ec30651f1934244afc8909a571ed9c4
Autor:
Christina Psaros, Georgia R. Goodman, Jasper S. Lee, Whitney Rice, Colleen F. Kelley, Temitope Oyedele, Lara E. Coelho, Nittaya Phanuphak, Yashna Singh, Keren Middelkoop, Sam Griffith, Marybeth McCauley, James Rooney, Alex R. Rinehart, Jesse Clark, Vivian Go, Jeremy Sugarman, Sheldon D. Fields, Adeola Adeyeye, Beatriz Grinsztejn, Raphael J. Landovitz, Steven A. Safren, the HPTN 083‐02 Study Team
Publikováno v:
Journal of the International AIDS Society, Vol 27, Iss 5, Pp n/a-n/a (2024)
Abstract Introduction HPTN 083 demonstrated the superiority of long‐acting cabotegravir (CAB‐LA) versus daily oral emtricitabine/tenofovir disoproxil fumarate (TDF/FTC) as pre‐exposure prophylaxis (PrEP) among cisgender men and transgender wome
Externí odkaz:
https://doaj.org/article/98512b389e2b4527adca150c40933567
Publikováno v:
BMC Neurology, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background The objective of this study was to evaluate and identify the risk factors for developing a new or enlarged intracranial hemorrhage (ICH) after the placement of an external ventricular drain. Methods A single center, nested case-co
Externí odkaz:
https://doaj.org/article/5569d71ea42e43f1b56278d3ab8b52b2
Autor:
Mark A. Marzinke, Jessica M. Fogel, Zhe Wang, Estelle Piwowar-Manning, Ryan Kofron, Amber Moser, Pradip Bhandari, Ryann Gollings, Lane R. Bushman, Lei Weng, Elias K. Halvas, John Mellors, Peter L. Anderson, Deborah Persaud, Craig W. Hendrix, Marybeth McCauley, Alex R. Rinehart, Marty St Clair, Susan L. Ford, James F. Rooney, Adeola Adeyeye, Suwat Chariyalertsak, Kenneth Mayer, Roberto C. Arduino, Myron S. Cohen, Beatriz Grinsztejn, Brett Hanscom, Raphael J. Landovitz, Susan H. Eshleman
Publikováno v:
Antimicrobial Agents and Chemotherapy. 67
HPTN 083 demonstrated that injectable cabotegravir (CAB) was superior to oral tenofovir disoproxil fumarate-emtricitabine (TDF-FTC) for HIV prevention in cisgender men and transgender women who have sex with men. We previously analyzed 58 infections
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Raphael J Landovitz, Sue Li, Beatriz Grinsztejn, Halima Dawood, Albert Y Liu, Manya Magnus, Mina C Hosseinipour, Ravindre Panchia, Leslie Cottle, Gordon Chau, Paul Richardson, Mark A Marzinke, Craig W Hendrix, Susan H Eshleman, Yinfeng Zhang, Elizabeth Tolley, Jeremy Sugarman, Ryan Kofron, Adeola Adeyeye, David Burns, Alex R Rinehart, David Margolis, William R Spreen, Myron S Cohen, Marybeth McCauley, Joseph J Eron
Publikováno v:
PLoS Medicine, Vol 15, Iss 11, p e1002690 (2018)
BACKGROUND:Cabotegravir (CAB) is a novel strand-transfer integrase inhibitor being developed for HIV treatment and prevention. CAB is formulated both as an immediate-release oral tablet for daily administration and as a long-acting injectable suspens
Externí odkaz:
https://doaj.org/article/830d37bc7c0d4f32b2594bc89a7448f5
Autor:
Tonia Poteat, Supriya Sarkar, Leigh Ragone, Keith Rawlings, Alex R Rinehart, Jennifer N Hill, Kyli Gallington, Karin S Coyne, Vani Vannappagari
Publikováno v:
Open Forum Infectious Diseases. 9
Background Use of daily oral HIV pre-exposure prophylaxis (DO PrEP) has increased steadily in the past several years, but patterns of racial disparities have emerged in PrEP uptake. Although Black and Hispanic people are disproportionately affected b
Autor:
Tonia Poteat, Supriya Sarkar, Leigh Ragone, Keith Rawlings, Alex R Rinehart, Jennifer N Hill, Kyli Gallington, Karin S Coyne, Vani Vannappagari
Publikováno v:
Open Forum Infectious Diseases. 9
Background Cisgender women continue to have low pre-exposure prophylaxis (PrEP) uptake in the US, despite making up almost 20% of new HIV infections. The gap between the number of women who would benefit from PrEP and those who use PrEP highlights th
Autor:
Travis Sanchez, S Wilson Beckham, Marissa J Hannah, O Winslow Edwards, Keith Rawlings, Alex R Rinehart, Supriya Sarkar, Patrick S Sullivan, Vani Vannappagari
Publikováno v:
Open Forum Infectious Diseases. 9
Background Daily oral (DO) HIV pre-exposure prophylaxis (PrEP) effectively prevents HIV acquisition, but few men who have sex with men (MSM) currently use it. Newer options, such as on-demand (OD) oral and long-acting injectable (LA) PrEP may improve
Autor:
Jeffrey J. Pompe, James R. Rinehart
This straightforward translation of environmental economics discusses issues and concerns that have long-lasting and often substantial effects. The authors bridge the gap between the natural and social sciences by examining how economic decisions int